Awakn Life Sciences Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AWKNF research report →
Companyawaknlifesciences.com
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
- CEO
- Anthony Tennyson
- IPO
- 2021
- Employees
- 6
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $2.71M
- P/E
- -0.28
- P/S
- 2.58
- P/B
- 2.97
- EV/EBITDA
- -1.13
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -103.97%
- Op Margin
- -614.85%
- Net Margin
- -611.40%
- ROE
- -429.34%
- ROIC
- -331.42%
Growth & Income
- Revenue
- $87.37K · -94.16%
- Net Income
- $-5,102,704 · 44.19%
- EPS
- $-0.13 · 63.89%
- Op Income
- $-3,926,493
- FCF YoY
- 68.07%
Performance & Tape
- 52W High
- $0.13
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 2.60
- Avg Volume
- 8.84K
Get TickerSpark's AI analysis on AWKNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AWKNF Coverage
We haven't published any research on AWKNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AWKNF Report →